Ludwig K. von Segesser

Ludwig K. von Segesser

Auto-generated profile, based on publicly available information

Ludwig K. von Segesser

Department of Cardiovascular Surgery, University Hospital Lausanne, Centre Hospitalier Universitaire Vaudois, CHUV, Rue du Bugnon 46, 1011Switzerland

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2006 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
ACAntonio F. Corno
Antonio F. Corno
MPMartin Prosi
Martin Prosi
PFPierre Fridez
Pierre Fridez
Paolo ZuninoPaolo Zunino
Paolo Zunino
AQAlfio Quarteroni
Alfio Quarteroni
LSLudwig K. von Segesser
Ludwig K. von Segesser
Objective: To evaluate the differences between non-circular shape of FloWatch®-PAB and conventional pulmonary artery (PA) banding. Methods:Geometrical analysis. Conventional banding and FloWatch®-PAB perimeters were plotted against cross-sections. Computational fluid dynamics (CFD) model. CFD compared non-circular FloWatch®-PAB cross-sections with conventional banding regarding pressure gradients. Clinical data. Seven children, median age 2 months (7 days to 3 years), median weight 4.2 kg (3.2–9.8 kg), with complex congenital heart defects underwent PA banding with FloWatch®-PAB implantation. Results:Geometrical analysis. Conventional banding: progressive reduction of cross-sections was accompanied by progressive reduction of PA perimeters. FloWatch®-PAB: with equal reduction of cross-sections the PA perimeter remained constant. CFD model. Non-circular and circular banding provided same trans-banding pressure gradients for same cross-sections at any given flow. Clinical data. Mean PA internal diameter at banding was 13.3 ± 4.5 mm. After a mean interval of 5.9 ± 3.7 months, all children underwent intra-cardiac repair and simple FloWatch®-PAB removal without PA reconstruction. Mean PA internal diameter with FloWatch®-PAB removal increased from 3.0 ± 0.8 to 12.4 ± 4.5 mm (normal mean internal diameter for the age = 9.9 ± 1.6). No residual pressure gradient was recorded in correspondence of the site of the previous FloWatch®-PAB implantation in 6/7 patients, 10 mmHg peak and 5 mmHg mean gradient in 1/7. Conclusions: The non-circular shape of FloWatch®-PAB can replace conventional circular banding with the following advantages: (a) the pressure gradient will remain essentially the same as for conventional circular banding for any given cross-section, but with significantly smaller reduction of PA perimeter; and (b) PA reconstruction at the time of de-banding for intra-cardiac repair can be avoided.

1 December 2009 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
BPBertrand R.M. Perrin
Bertrand R.M. Perrin
MDMichel Dupeux
Michel Dupeux
PTPiergiorgio Tozzi
Piergiorgio Tozzi
DDDominique Delay
Dominique Delay
PGPhilippe Gersbach
Philippe Gersbach
LSLudwig K. von Segesser
Ludwig K. von Segesser
Objective: The aim of this study is to create a standard test to approve the efficacy of a surgical sealant. An industrial test, the bulge-and-blister test, which is very convenient for measuring adhesion energy, is applied to the surgical field to quantify adhesion of bioadhesives. Methods: Samples were composed of two circular layers of equine pericardium glued by the surgical sealant studied. The sample was fixed to a support with an industrial glue. The support and the bottom layer were perforated in the centre to allow injection of pressurised water. Water was progressively introduced through the hole in the support and the bottom layer to create a blister with constant radius, increasing height and internal pressure during this first step. At a critical pressure, delamination started, the radius and height of the blister increased and the pressure decreased. At this point, the adhesion energy could be determined. The experimental parameters were measured with a pressure sensor and an optical profilometry device for deflection. Results: Adhesion testing was carried out in eight paired equine pericardium samples bonded with a Dermabond® cyanoacrylate glue. The average value of the practical adhesion energy is 2.3 J m−2 with a standard deviation of 1.5 J m−2. Conclusion: Application of the bulge-and-blister test to the surgical field was achieved and allowed a quantification of adhesion of a surgical glue. Such information is essential to compare the different surgical glues presently available. The study of the impact of bonding conditions such as pressure, hygrometry or setting conditions will provide a better understanding of the characteristics of adhesion in the surgical field.

1 October 2012 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
NSNicole Sekarski
Nicole Sekarski
MHMichel Hurni
Michel Hurni
LSLudwig K. von Segesser
Ludwig K. von Segesser
EMErik J. Meijboom
Erik J. Meijboom
SBStefano Di Bernardo
Stefano Di Bernardo

1 March 2012 in ASAIO Journal
Verified
Journal Article
Closed access
PTPiergiorgio Tozzi
Piergiorgio Tozzi
AMAlexandre Michalis
Alexandre Michalis
DHDaniel Hayoz
Daniel Hayoz
DLDidier Locca
Didier Locca
LSLudwig K. von Segesser
Ludwig K. von Segesser
We describe a device made of artificial muscle for the treatment of end-stage heart failure as an alternative to current heart assist devices. The key component is a matrix of nitinol wires and aramidic fibers called Biometal muscle (BM). When heated electrically, it produces a motorless, smooth, and lifelike motion. The BM is connected to a carbon fiber scaffold, tightening the heart and providing simultaneous assistance to the left and right ventricles. A pacemaker-like microprocessor drives the contraction of the BM. We tested the device in a dedicated bench model of diseased heart. It generated a systolic pressure of 75 mm Hg and ejected a maximum of 330 ml/min, with an ejection fraction of 12%. The device required a power supply of 6 V, 250 mA. This could be the beginning of an era in which BMs integrate or replace the mechanical function of natural muscles.

1 April 2006 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
DJDavid Jegger
David Jegger
PCPierre-Guy Chassot
Pierre-Guy Chassot
MBMarc-Andre Bernath
Marc-Andre Bernath
JHJudith Horisberger
Judith Horisberger
PGPhilippe Gersbach
Philippe Gersbach
LSLudwig K. von Segesser
Ludwig K. von Segesser
The use of ultrasound techniques has become routine in cardiac surgery in order to help the clinicians in optimising diagnosis preoperatively (transthoracic echocardiography (TTE)) and perioperatively (transoesophageal echocardiography (TOE)) by validating surgical techniques such as mitral valvuloplasties, identifying dyskinetic myocardial zones postcoronary artery bypass graft (CABG) procedures and assuring the absence of paravalvular leaks postvalve replacement.

1 February 2008 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
PTPiergiorgio Tozzi
Piergiorgio Tozzi
DHDaniel Hayoz
Daniel Hayoz
PTPierrick Thévenaz
Pierrick Thévenaz
JRJean-Yves Roulet
Jean-Yves Roulet
FSFrancois Salchli
Francois Salchli
LSLudwig K. von Segesser
Ludwig K. von Segesser
Objective: The Maze procedure can restore sinus rhythm in patients suffering from chronic atrial fibrillation but often fails to restore the mechanical function of the atrium, the so-called atrial kick and requires long-term anticoagulation most of the time. A micro motorless pump (Atripump) based on artificial muscle technology positioned on the external surface of the atrium could compress the heart chamber, restoring atrium transport function. A bench model reproducing the mechanical function of human atrium and human environment has been developed to assess the circulatory support that such a pump can provide. Methods: Atripump (Nanopowers SA, Switzerland) is a dome-shape, silicone-coated nitinol actuator to be sutured on the external surface of the atrium. A pacemaker-like control unit drives the actuator and manages the external compression of the atrium. The bench model consists of an open circuit made of rubber bladder, 60 cc in volume, connected to a vertically positioned and scaled tube that is filled at different levels reproducing changes in cardiac pre-load and after-load. The pump was placed on the outer surface of the bladder and both were immersed in water having a constant temperature of 37 °C. Pressure, volume and temperature at the interface dome–bladder were recorded. Results: Pump ran 24 h for three consecutive months. During the experiment, no technical failure occurred and the pressure and volume values were repeatable during the experience. Nitinol fatigue was assessed measuring the wire’s electric resistance that remained 400 ± 10 Ω/m. Contraction rate was 1 Hz with power supply of 12 V, 400 m and heating time of 300 ms. Pre-load ranged from 11 to 15 mmHg. When inserted in the bath at 37 ± 0.5 °C, maximal temperature between silicone membrane and rubber bladder was 39 °C. Maximal volume pumped was 492 ml/min. Conclusions: This artificial muscle pump can reproduce the mechanical effect of a normal human atrium. It is compact, reliable and follows the Starling law. The surface temperature is in the physiologic range and it could represent a new tool to restore the atrial kick in persistent atrial fibrillation.